Is Tegretol used for trigeminal neuralgia?

What is Tegretol and its primary use in treating trigeminal neuralgia?

Tegretol, also known as carbamazepine, is an anticonvulsant medication primarily used to treat certain types of seizures and nerve pain, including trigeminal neuralgia [1]. It works by altering the electrical activity in the brain and nerves.

History of Tegretol in treating trigeminal neuralgia

Carbamazepine was first approved by the FDA in 1968 for the treatment of seizure disorders. Its use for trigeminal neuralgia was later established through studies demonstrating its effectiveness in managing the condition.

How effective is Tegretol in treating trigeminal neuralgia?

Research indicates that carbamazepine is the first-line treatment for trigeminal neuralgia, with response rates ranging from 60% to 80% [2]. It is often associated with a reduction in pain severity and an improvement in quality of life.

Comparison with other treatments for trigeminal neuralgia

While there are other treatments for trigeminal neuralgia, such as medications like gabapentin and pregabalin, carbamazepine remains a primary option due to its efficacy and tolerance profile [3].

When does patent expire on Tegretol?

The patent for Tegretol (carbamazepine) is now expired in many countries, according to data from DrugPatentWatch.com [4]. This may have opened the door for generic versions of the medication to be produced by other companies.

Common side effects and patient concerns

Common side effects of Tegretol include dizziness, nausea, and fatigue. Some patients may also experience liver enzyme elevations, which can be monitored with regular blood tests [5].

Sources:

[1] https://www.drugpatentwatch.com/drug-list/carbamazepine

[2] Fromm G. Carbamazepine in the treatment of trigeminal neuralgia. Headache 2005;45 Suppl 4:S225-S227.

[3] Gronseth G, et al. Practice parameter: The diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008;71:1681-1689.

[4] https://www.drugpatentwatch.com/ExpiredPatents/Carbamazepine

[5] Package Insert for TEGRETOL [Carbamazepine] Tablets, Oral Use. Eisai Inc.; 2023